When did Matinas BioPharma report Q4 2024 earnings?

Matinas BioPharma (MTNB) reported Q4 2024 earnings on March 26, 2025 before market open.

What were Matinas BioPharma's Q4 2024 revenue and EPS?

Matinas BioPharma reported revenue of $962.0K and eps of $-1.50 for Q4 2024.

EPS missed the consensus estimate of $-0.78 by $0.72.

Reported March 26, 2025 · Before market open

Revenue$962.0K

EPS-$1.50Miss by $0.72

EPS estimate-$0.78

Aug 13, 2026 (In 2 weeks)

Revenue estimate$25.0K

EPS estimate-$1.50

Q4 2024$962.0K

Q4 2024-$1.50Miss by $0.72

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did Matinas BioPharma report Q4 2024 earnings?: Matinas BioPharma (MTNB) reported Q4 2024 earnings on March 26, 2025 before market open.
What were Matinas BioPharma's Q4 2024 revenue and EPS?: Matinas BioPharma reported revenue of $962.0K and eps of $-1.50 for Q4 2024.
Did Matinas BioPharma beat estimates in Q4 2024?: EPS missed the consensus estimate of $-0.78 by $0.72.